Showing 731-740 of 1043 results for "".
Ruling Out Secondary Headache
https://practicalneurology.com/diseases-diagnoses/headache-pain/ruling-out-secondary-headache/30260/A careful history and high degree of suspician are needed for accurate diagnosis.Preclinical, Prodromal, and Dementia Stages of Alzheimer’s Disease
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/preclinical-prodromal-and-dementia-stages-ofalzheimers-disease/31531/Identifying the correct stage of Alzheimer’s disease helps in managing risk, diagnosis, and management decisions.Kappa Free Light Chain Index in the Diagnosis of Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/kappa-free-light-chain-index-in-the-diagnosis-of-multiple-sclerosis/54598/Adoption of the kappa free light chain index can enhance diagnostic accuracy and reduce latency in multiple sclerosis diagnosis, complementing MRI and expert assessment in clinical decision-making.Incorporating the Lived Experience of Patients and Caregivers From Dementia Diagnosis Through the Caregiving Journey
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/incorporating-the-lived-experience-of-patients-and-caregivers-from-dementia-diagnosis-through-the-caregiving-journey/32143/An interview detailing practical steps neurologists can take to clearly and compassionately deliver traumatic diagnoses and highlighting helpful recommendations and resources designed to help neurologists partner with and support caregivers.The Emerging Landscape of Targeted Therapeutics for Genetic Neuromuscular Disorders
https://practicalneurology.com/diseases-diagnoses/neuromuscular/the-emerging-landscape-of-targeted-therapeutics-for-genetic-neuromuscular-disorders/32023/Advances in targeted therapeutics for neuromuscular disease have profoundly altered clinical approaches to these disorders and the use of genetic testing.Discontinuing Disease-Modifying Therapy in Multiple Sclerosis: Should You Have an Exit Strategy?
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/discontinuing-disease-modifying-therapy-in-multiple-sclerosis-should-you-have-an-exit-strategy/30303/Two experts sound off on the implications of indefinite treatment and whether DMTs should be stopped.Measuring Orientation: A New Approach to Concussion Screening and Treatment
https://practicalneurology.com/diseases-diagnoses/tbi/measuring-orientation-a-new-approach-to-concussion-screening-and-treatment/30364/Assessing orientation offers a viable means of concussion screening and measuring the neurological impact of head injuries.Cannabinoids and the Endocannabinoid System: Emerging Trends
https://practicalneurology.com/diseases-diagnoses/headache-pain/cannabinoids-and-the-endocannabinoid-system-emerging-trends/30406/Cannabis-derived therapies may offer a great opportunity to modulate the endocannabinoid system, but understanding the risks is paramount.Cardiac Cephalgia
https://practicalneurology.com/diseases-diagnoses/headache-pain/cardiac-cephalgia/31657/Some cardiac workup is a necessary part of headache evaluation to assess for secondary headache and potential risks of available headache treatments.Quality of Life for Older People With Epilepsy
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/quality-of-life-for-older-people-with-epilepsy/32178/Focusing on all aspects of health and well-being when treating older adults with epilepsy is important for improving quality of life.